Biological insights from genome-wide association in schizophrenia

Wed3  Sep11:00am(30 mins)
Charter 4


Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of alleles, including common alleles of small effect that might be detected by genome-wide association studies. A recent multi-stage schizophrenia genome-wide association study of 37,000 cases and 113,000 controls identified 128 independent genetic associations that meet genome-wide significance. Associations were enriched among genes expressed in. Associations at the dopamine D2 receptor DRD2, encoding the principal drug target for antipsychotics, and multiple genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses.

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2021